Home › Funds › Aspex Management (HK) Ltd › CVNA
Aspex Management (HK) Ltd position in CVNA
CARVANA CO · Consumer Discretionary
Aspex Management (HK) Ltd reported holding 10,891,999 shares of CVNA (CARVANA CO) in its Q2 2026 13F filing — a position valued at US$716.9M, representing 9.54% of its reported portfolio and ranking #4 among its reported holdings. Aspex Management (HK) Ltd has disclosed CVNA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Aspex Management (HK) Ltd's CVNA position evolved
Aspex Management (HK) Ltd first disclosed a stake in CVNA in Q1 2026 at 1,819,090 shares (US$571.9M). The position peaked in Q2 2026 at 10,891,999 shares, worth US$716.9M. Across 2 filings, Aspex Management (HK) Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 10,891,999 shares valued at US$716.9M — an increase of 9,072,909 shares quarter over quarter.. Notable position changes include a 499% increase in Q2 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.82M | $571.89M | New |
| Q2 2026 | 10.89M | $716.91M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVNA and 13F data
CVNA (CARVANA CO) is a Consumer Discretionary company. 46 other funds we track also report a position in CVNA — the largest reported positions include PRICE T ROWE ASSOCIATES INC /MD/ (US$5.57B), Capital Research Global Investors (US$4.17B), Capital Research Global Investors (US$4.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVNA
- PRICE T ROWE ASSOCIATES INC /MD/ 84.70M sh · $5.57B · Q2 2026
- Capital Research Global Investors 63.42M sh · $4.17B · Q2 2026
- Capital Research Global Investors 63.42M sh · $4.17B · Q2 2026
- CAS Investment Partners, LLC 22.56M sh · $1.48B · Q2 2026
- GREENOAKS LLC 21.34M sh · $1.40B · Q2 2026
- Viking Global Investors 12.32M sh · $811.05M · Q2 2026
- VIKING GLOBAL INVESTORS LP 12.32M sh · $811.05M · Q2 2026
- SPRUCE HOUSE INVESTMENT MANAGEMENT LLC 11.68M sh · $768.45M · Q2 2026
- Lone Pine Capital 10.52M sh · $692.47M · Q2 2026
- LONE PINE CAPITAL LLC 10.52M sh · $692.47M · Q2 2026
- Lingotto Investment Management LLP 9.28M sh · $611.06M · Q2 2026
- SANDS CAPITAL MANAGEMENT, LLC 8.46M sh · $557.03M · Q2 2026
More on Aspex Management (HK) Ltd
FAQ
How long has Aspex Management (HK) Ltd held CVNA?
Aspex Management (HK) Ltd has disclosed CVNA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Aspex Management (HK) Ltd's current position in CVNA?
As of Q2 2026, Aspex Management (HK) Ltd holds 10.89M shares of CVNA (CARVANA CO), valued at $716.91M, representing 9.54% of its reported portfolio and ranking #4.
Has Aspex Management (HK) Ltd been buying or selling CVNA?
In the latest 13F filing (Q2 2026), Aspex Management (HK) Ltd increased its position in CVNA. The position peaked in Q2 2026 at 10.89M shares.
Which other funds hold CVNA?
Other major institutional holders of CVNA include PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors, Capital Research Global Investors, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.